Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
07/2008
07/30/2008EP1948645A1 Tricyclo substituted amides
07/30/2008EP1948600A2 Liver targeted conjugates
07/30/2008EP1948592A1 Organic compounds
07/30/2008CN101233124A Glycolipid derivative and therapeutic agent comprising the same as active ingredient
07/30/2008CN101233123A Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid
07/30/2008CN101230055A Lovastatin analogue as well as preparation method and uses thereof
07/30/2008CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
07/29/2008US7405309 e.g. iodomethylene-dimethyl-dihydropyranone; novelty of the chemical structure and of the mechanism of action; alkylation aldehyde with methyl [bis(2,2,2-trifluoroethyl)phosphinoyl]acetate followed by cyclization
07/29/2008US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/24/2008WO2008065181A3 Pyran derivatives, process of preparation and use thereof in perfumery and flavouring
07/24/2008WO2008065181A2 Pyran derivatives, process of preparation and use thereof in perfumery and flavouring
07/23/2008CN101228116A Benzoyl-substituted serineamides
07/23/2008CN100404522C Process for producing a pyran compound
07/22/2008US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/16/2008CN100403577C Red organic electroluminescent element
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
07/10/2008WO2008026140A3 Malodor counteracting compositions and method for their use
07/10/2008US20080167478 high binding affinity to dopamine, serotonin and norepinephrine transport proteins, used as antidepressants, for tratment of drug abuse and Parkinson's disease
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008CN101218220A Choline salt crystal of azulene compound
07/09/2008CN101215307A Method for preparing hydroxyl carthamus tinctorius yellow color A
07/09/2008CN100400533C Valerolactone compounds and perfume composition
07/09/2008CN100400532C Chiral 3,4-dihydro-2h-pyran compounds
07/08/2008US7396898 Diamine, acid dianhydride, and reactive group containing polyimide composition prepared therefrom and process of preparing them
07/03/2008WO2008053206A3 Process for preparation of aldonic acids and derivatives thereof
07/03/2008US20080161582 Made by therification of 4-Methoxy-6-trifluoromethylpyran-2-one with dimethyl sulfate, converting to the alkyl ester with an alkali or alkaline earth metal alcoholate; chemical intermediate for insecticides; 4-Methoxy-6-trifluoromethylpyran-2-one
07/03/2008US20080161362 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/02/2008EP1937696A1 PROCESS FOR THE SYNTHESIS OF HMG-CoA REDUCTASE INHIBITORS
07/02/2008EP1937661A1 Spiro [3.3] heptyl-dioxan derivatives and their use in liquid crystal media
07/02/2008EP1937248A2 Alcanoic acid amides substituted by saturated o-heterocycles
07/02/2008EP1451181B1 Dimeric compounds and their use as anti-viral agents
07/02/2008EP1423385B1 Intermediates for preparing neuraminidase inhibitor conjugates
07/02/2008CN101213170A Process for production of 4-biphenylylazetidin-2-ones
07/01/2008US7393873 Arylsulfonamide derivatives
06/2008
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008053360A3 Albumin binding molecules and uses thereof
06/26/2008WO2008036247A8 Renin inhibitors
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153836 1H-Quinazoline-2,4-Diones
06/26/2008US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/26/2008US20080153732 mixture contains a lactone, cyclic carbonate and solvents of a glycol ether, for cleaning silicon wafer, an organic electroluminescence material, photosensitive resin, liquid crystal or wax
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/25/2008EP1934388A1 Method of drug design
06/25/2008EP1934195A1 Method for producing lactones
06/25/2008CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
06/25/2008CN101205225A Method for preparing lactones by biomimetic catalytic oxidation of ketone compounds
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/19/2008WO2008071948A2 Aminoalcohol derivatives and their therapeutic use
06/19/2008WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008CA2672238A1 Aminoalcohol derivatives and their therapeutic use
06/19/2008CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/18/2008CN101200470A Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof
06/18/2008CN100395242C Naphthalene alkoxy and naphthaquinone kind pyrane carbonic glucoside compound and preparation process thereof
06/17/2008US7388118 Amine 1,2- and 1,3-diol compounds
06/12/2008WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols
06/12/2008WO2008042688A3 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
06/12/2008WO2008034859A8 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
06/12/2008US20080139828 Production Process Of Tetrahydropyran Compound And Tetrahydropyran Compound Produced By The Production Process
06/12/2008US20080139505 Potentiators Of Glutamate Receptors
06/12/2008US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
06/12/2008US20080138297 2-(Cyclopent-3-enylmethyl)-tetrahydropyran derivatives; alkylation, esterification, acetalization; cosmetics, cleaning compounds, shampoo, mouthwashes, dentrifices, detergents, antiperspirants, dairy products, baked goods, air deodorizers, foods, drugs, wine, beer, tobacco, soups, ice cream, meats
06/12/2008CA2671179A1 Biphenyl-substituted spirocyclic ketoenols
06/11/2008EP1928852A2 Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
06/11/2008EP1451184B1 Dimeric compounds and their use as anti-viral agents
06/11/2008EP1451182B1 Dimeric compounds and their use as anti-viral agents
06/11/2008CN101198600A Synthesis of hydroquinone derivatives
06/11/2008CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/05/2008WO2008065493A1 Pyrazole analogs
06/05/2008US20080132716 Fluorophenyl compounds for liquid-crystalline mixtures
06/04/2008EP1927593A1 Pyran derivates, process of preparation and use thereof in perfumery and flavouring
06/04/2008EP1926720A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
06/04/2008EP1926500A2 Methods of making radiolabeled tracers and precursors thereof
06/04/2008CN101193879A Catalytic preparation of cyclic carboxylic esters
06/04/2008CN101190907A Method for synthesizing statins compounds
06/04/2008CN101190906A Method for preparing carthamin yellow carthamus B and application thereof
06/03/2008CA2389360C Urea derivatives as anti-inflammatory agents
05/2008
05/29/2008US20080125474 Pyrazole Analogs
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/28/2008EP1924571A2 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
05/28/2008CN101186601A Method for catalyzing cyclone oxide to synthesizing lactone by using nano magnesium-base catalyst
05/28/2008CN100390167C Total synthesis of myriaporones
05/27/2008US7378548 Michael addition of an acrylic acid ester to a secondary amine such as diethanolamine; additives in chemical amplification photolithography giving photoresists with high resolution and excellent focus margin
05/27/2008US7378412 Pharmaceutical compounds
05/22/2008US20080119558 Drug for Inhibiting Production of Matrix Metalloprotease-9
05/22/2008US20080119512 Carboxamide Derivatives as Therapeutic Agents
05/22/2008US20080119486 Benzoyl-piperazine derivatives
05/21/2008EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them.
05/21/2008EP1603557A4 Synthesis of peloruside a and analogs thereof for use as antitumor agents
05/21/2008EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008CN101184405A Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/15/2008WO2008055870A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008CA2668623A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
05/14/2008EP1919452A2 Application of a bioactive agent to a substrate
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 129